Last reviewed · How we verify

Inhaled nitroglycerin

Beni-Suef University · Phase 2 active Small molecule Quality 0/100

Inhaled nitroglycerin is a Small molecule drug developed by Beni-Suef University. It is currently in Phase 2 development.

At a glance

Generic nameInhaled nitroglycerin
SponsorBeni-Suef University
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Inhaled nitroglycerin

What is Inhaled nitroglycerin?

Inhaled nitroglycerin is a Small molecule drug developed by Beni-Suef University.

Who makes Inhaled nitroglycerin?

Inhaled nitroglycerin is developed by Beni-Suef University (see full Beni-Suef University pipeline at /company/beni-suef-university).

What development phase is Inhaled nitroglycerin in?

Inhaled nitroglycerin is in Phase 2.

Related